Filed: 7/24/2023ACC: 0001104659-23-083441
📋 What this filing means
QIMING U.S. VENTURES MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $95.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$95.17M
Total AUM (reported)
19.47M
Total Shares
Allocation by class
COM$95.17M100.0%
Portfolio Concentration
Top 3$71.01M74.6%
4–10$24.16M25.4%
Top 3 weight
74.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 19.47M
Sole
Full voting authority
19.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
ICOSAVAX INC
SOLEShares3.51M
TypeSH
Market value$34.86M
36.63%
Sole
3.51M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares746.37K
TypeSH
Market value$24.48M
25.72%
Sole
746.37K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares8.52M
TypeSH
Market value$11.67M
12.26%
Sole
8.52M
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares558.92K
TypeSH
Market value$9.61M
10.10%
Sole
558.92K
Shared
0.00
None
0.00
TALARIS THERAPEUTICS INC
SOLEShares2.93M
TypeSH
Market value$8.92M
9.37%
Sole
2.93M
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares2.37M
TypeSH
Market value$3.60M
3.79%
Sole
2.37M
Shared
0.00
None
0.00
KEZAR LIFE SCIENCES INC
SOLEShares828.71K
TypeSH
Market value$2.03M
2.13%
Sole
828.71K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ICOSAVAX INCSOLE | COM | 3.51M | SH | $34.86M 36.63% | 3.51M | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 746.37K | SH | $24.48M 25.72% | 746.37K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM | 8.52M | SH | $11.67M 12.26% | 8.52M | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 558.92K | SH | $9.61M 10.10% | 558.92K | 0.00 | 0.00 |
TALARIS THERAPEUTICS INCSOLE | COM | 2.93M | SH | $8.92M 9.37% | 2.93M | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 2.37M | SH | $3.60M 3.79% | 2.37M | 0.00 | 0.00 |
KEZAR LIFE SCIENCES INCSOLE | COM | 828.71K | SH | $2.03M 2.13% | 828.71K | 0.00 | 0.00 |